526 related articles for article (PubMed ID: 36707884)
21. Pyroptosis-related gene mediated modification patterns and immune cell infiltration landscapes in cutaneous melanoma to aid immunotherapy.
Meng J; Huang X; Qiu Y; Zheng X; Huang J; Wen Z; Yao J
Aging (Albany NY); 2021 Nov; 13(21):24379-24401. PubMed ID: 34753832
[TBL] [Abstract][Full Text] [Related]
22. Molecular subtypes identified by pyroptosis-related genes are associated with tumor microenvironment cell infiltration in colon cancer.
Ling Y; Wang Y; Cao C; Feng L; Zhang B; Li S
Aging (Albany NY); 2022 Nov; 14(22):9020-9036. PubMed ID: 36384889
[TBL] [Abstract][Full Text] [Related]
23. Construction and comprehensive analysis of a novel prognostic signature associated with pyroptosis molecular subtypes in patients with pancreatic adenocarcinoma.
Huang Q; Peng X; Li Q; Zhu J; Xue J; Jiang H
Front Immunol; 2023; 14():1111494. PubMed ID: 36817451
[TBL] [Abstract][Full Text] [Related]
24. Identification of an Autophagy-Related Signature for Prognosis and Immunotherapy Response Prediction in Ovarian Cancer.
Ding J; Wang C; Sun Y; Guo J; Liu S; Cheng Z
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830707
[TBL] [Abstract][Full Text] [Related]
25. Comprehensive pan-cancer analysis of role of GPRASP1, associated with clinical outcomes, immune microenvironment, and immunotherapeutic efficiency in pancreatic cancer.
Du J; Chen Y; Liu G; Zeng Q; Zhou N; Du D
Pathol Res Pract; 2023 Mar; 243():154374. PubMed ID: 36801507
[TBL] [Abstract][Full Text] [Related]
26. Pyroptosis-related gene expression patterns and corresponding tumor microenvironment infiltration characterization in ovarian cancer.
Liu J; Chen C; Geng R; Shao F; Yang S; Zhong Z; Ni S; Bai J
Comput Struct Biotechnol J; 2022; 20():5440-5452. PubMed ID: 36249562
[TBL] [Abstract][Full Text] [Related]
27. Construction of an Immune Cell Infiltration Score to Evaluate the Prognosis and Therapeutic Efficacy of Ovarian Cancer Patients.
Liu J; Wang Y; Yuan S; Wei J; Bai J
Front Immunol; 2021; 12():751594. PubMed ID: 34745124
[TBL] [Abstract][Full Text] [Related]
28. Identification and validation of immunotherapy for four novel clusters of colorectal cancer based on the tumor microenvironment.
Zheng X; Ma Y; Bai Y; Huang T; Lv X; Deng J; Wang Z; Lian W; Tong Y; Zhang X; Yue M; Zhang Y; Li L; Peng M
Front Immunol; 2022; 13():984480. PubMed ID: 36389763
[TBL] [Abstract][Full Text] [Related]
29. A lactate metabolism-related signature predicting patient prognosis and immune microenvironment in ovarian cancer.
Zhu L; Lin Z; Wang K; Gu J; Chen X; Chen R; Wang L; Cheng X
Front Endocrinol (Lausanne); 2024; 15():1372413. PubMed ID: 38529390
[TBL] [Abstract][Full Text] [Related]
30. Pyroptosis-Mediated Molecular Subtypes are Characterized by Distinct Tumor Microenvironment Infiltration Characteristics in Breast Cancer.
Xu L; Hu Y; Liu W
J Inflamm Res; 2022; 15():345-362. PubMed ID: 35079221
[TBL] [Abstract][Full Text] [Related]
31. Cross-talk of pyroptosis and tumor immune landscape in lung adenocarcinoma.
Wang X; Lin W; Liu T; Xu Z; Wang Z; Cao Z; Feng X; Gao Y; He J
Transl Lung Cancer Res; 2021 Dec; 10(12):4423-4444. PubMed ID: 35070752
[TBL] [Abstract][Full Text] [Related]
32. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.
Chen H; Yao J; Bao R; Dong Y; Zhang T; Du Y; Wang G; Ni D; Xun Z; Niu X; Ye Y; Li HB
Mol Cancer; 2021 Feb; 20(1):29. PubMed ID: 33557837
[TBL] [Abstract][Full Text] [Related]
33. Genomic, Immunological, and Clinical Characterization of Pyroptosis in Ovarian Cancer.
Zhou M; Li B; Liu J; Hong L
J Inflamm Res; 2021; 14():7341-7358. PubMed ID: 34992421
[TBL] [Abstract][Full Text] [Related]
34. Prediction of lung squamous cell carcinoma immune microenvironment and immunotherapy efficiency with pyroptosis-derived genes.
Deng X; Wang Z; Luo Y; Li Z; Chen L
Medicine (Baltimore); 2022 Sep; 101(37):e30304. PubMed ID: 36123889
[TBL] [Abstract][Full Text] [Related]
35. Novel immune-related gene signature for risk stratification and prognosis prediction in ovarian cancer.
Fei H; Han X; Wang Y; Li S
J Ovarian Res; 2023 Oct; 16(1):205. PubMed ID: 37858138
[TBL] [Abstract][Full Text] [Related]
36. A pyroptosis-related gene signature predicts prognosis and immune microenvironment in hepatocellular carcinoma.
Jin Y; Pu X; Ping D; Huang C; Ding G; Cao L
World J Surg Oncol; 2022 Jun; 20(1):179. PubMed ID: 35659304
[TBL] [Abstract][Full Text] [Related]
37. An immune-related exosome signature predicts the prognosis and immunotherapy response in ovarian cancer.
Zhu K; Ma J; Tian Y; Liu Q; Zhang J
BMC Womens Health; 2024 Jan; 24(1):49. PubMed ID: 38238671
[TBL] [Abstract][Full Text] [Related]
38. Adipocyte pyroptosis occurs in omental tumor microenvironment and is associated with chemoresistance of ovarian cancer.
Lin CN; Liang YL; Tsai HF; Wu PY; Huang LY; Lin YH; Kang CY; Yao CL; Shen MR; Hsu KF
J Biomed Sci; 2024 Jun; 31(1):62. PubMed ID: 38862973
[TBL] [Abstract][Full Text] [Related]
39. Machine learning developed a CD8
Chen R; Zheng Y; Fei C; Ye J; Fei H
Sci Rep; 2024 Mar; 14(1):5794. PubMed ID: 38461331
[TBL] [Abstract][Full Text] [Related]
40. Immune Infiltrating Cells-Derived Risk Signature Based on Large-scale Analysis Defines Immune Landscape and Predicts Immunotherapy Responses in Glioma Tumor Microenvironment.
Zhang N; Zhang H; Wang Z; Dai Z; Zhang X; Cheng Q; Liu Z
Front Immunol; 2021; 12():691811. PubMed ID: 34489938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]